For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Maintenance Lenalidomide in Lymphoma | Total of twenty-four (24) 28-day cycles of lenalidomide, 10mg, oral tablets, daily Lenalidomide: Lenalidomide, 10mg, oral tablets, daily | 2 | None | 0 | 6 | 3 | 6 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| White blood cell decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE Version 4.0 | View |
| Neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE Version 4.0 | View |
| Fatigue (Grade 1) | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE Version 4.0 | View |
| Fatigue (Grade 2) | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE Version 4.0 | View |
| Cough (Grade 2) | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE Version 4.0 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE Version 4.0 | View |
| Lung Infection | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE Version 4.0 | View |
| Sinusitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE Version 4.0 | View |
| Hypogammaglobunemia | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCAE Version 4.0 | View |